Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

95.05 -1.38 (-1.43%)
Official Closing Price Updated: 7:00 PM EST, Nov 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,662,978
Open 96.00
Bid (Size) 94.55 (100)
Ask (Size) 96.00 (100)
Prev. Close 96.43
Today's Range 94.09 - 97.14
52wk Range 73.31 - 105.07
Shares Outstanding 2,531,374,696
Dividend Yield 3.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices ↗
Via Stocktwits
Topics Workforce
News headline image
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗
Via MarketBeat

Performance

YTD
-4.2%
-4.2%
1 Month
+10.1%
+10.1%
3 Month
+12.3%
+12.3%
6 Month
+23.5%
+23.5%
1 Year
-1.5%
-1.5%

More News

Read More
News headline image
Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment ↗
Via Benzinga
Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study ↗
Via Stocktwits
News headline image
Why GRAIL Stock Could Be Biotech’s Next Big Breakout ↗
Via MarketBeat
News headline image
Healthcare Rotation Underway: 3 Stocks Leading the Charge ↗
Via MarketBeat
News headline image
Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Naïve Adults with HIV-1 Infection
From Merck & Co., Inc.
Via Business Wire
News headline image
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
From Merck & Co., Inc.
Via Business Wire
News headline image
Healthcare Sector Navigates Volatile Markets: A Defensive Anchor or Driven by Innovation?
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Market Movers in Motion: Merck & Co. and Amer Sports Chart Volatile Courses
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything ↗
Via MarketBeat
News headline image
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? ↗
Via Benzinga
News headline image
Which S&P500 stocks have an unusual volume on Tuesday? ↗
Via Chartmill
News headline image
Merck's Winrevair Success Extends Beyond Pulmonary Hypertension, Showing Promise In Complex Heart Condition ↗
Via Benzinga
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Merck Announces First-Quarter 2026 Dividend
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck Jumps On A Surprise Win; Why It Still Has A Long Road To Go ↗
Via Investor's Business Daily
Topics Government
News headline image
Top S&P500 movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
Via Investor's Business Daily
News headline image
Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)
From Merck & Co., Inc.
Via Business Wire
News headline image
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
Via Benzinga
Topics ETFs
News headline image
Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗
Via Benzinga

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 95.05
When was Merck & Co last traded?
The last trade of Merck & Co was at 11/19/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 240.61B
How many shares of Merck & Co are outstanding?
Merck & Co has 241B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.